The analysis of the relationship between the CXCL1 concentration and the tumor stage based on the TNM classification revealed that serum concentrations of this protein were higher in the early stages of cancer (stage I and II) in comparison to advanced CRC (stage III + IV), which is similar for CXCR1. The gene discussed is CXCL1; the disease is cancer.